Logo

CGCT

Cartesian Growth Corporation III

CGCT

Cartesian Growth Corporation III • NASDAQ
$10.15 ▲ 0.20% (+0.02)
Market Cap $280.14 M
52w High $10.15
52w Low $10.00
Dividend Yield 0%
P/E 0
Volume 50
Outstanding Shares 27.60M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $0 $0 ▼ $2.212M ▲ 0% $0.08 ▲ $0 ▲
Q2-2025 $0 $448.578K ▲ $1.319M ▲ 0% $0.056 ▲ $-448.578K ▼
Q1-2025 $0 $20.449K $-20.449K 0% $-0.001 $-20.449K

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $660.638K ▼ $281.56M ▲ $13.536M ▼ $-12.645M ▼
Q2-2025 $827.241K ▲ $278.821M ▲ $13.562M ▲ $265.26M ▲
Q1-2025 $0 $705.94K $744.009K $-38.069K

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q2-2025 $1.319M ▲ $-301.421K ▼ $-276M ▼ $277.129M ▲ $827.241K ▲ $-301.421K ▼
Q1-2025 $-20.449K $0 $0 $0 $0 $0

Five-Year Company Overview

Income Statement

Income Statement Cartesian Growth Corporation III is a pure “blank check” SPAC, so its income statement is not yet informative in the usual sense. It has no real revenue or operating business, and any small losses are mainly related to setup, listing, and ongoing public company costs. Until a merger target is announced and combined, there is no underlying operating performance to analyze, only the cost of keeping the SPAC structure in place.

Balance Sheet

Balance Sheet The balance sheet, as shown, is essentially empty because the operating business does not yet exist. In practice, a SPAC’s balance sheet is usually dominated by cash held in trust and offsetting shareholder interests and liabilities linked to the IPO structure. For now, there are no meaningful productive assets, no operating liabilities, and no real equity story beyond the sponsor capital and any IPO proceeds once raised. The financial health of the vehicle will depend less on traditional leverage and more on how the trust is protected and ultimately deployed in a deal.

Cash Flow

Cash Flow Current cash flows are largely administrative: money going out to cover legal, advisory, and listing expenses, with no operating cash coming in. There is no capital spending on plants, technology, or growth projects because there is no active business. The most important future cash flow event will be the use of IPO funds and any additional financing when a merger is executed, including potential redemptions by shareholders at that time.

Competitive Edge

Competitive Edge As a SPAC, CGCT competes not through products, but through its ability to attract an attractive private company to merge with. Its main strengths are an experienced sponsor, Cartesian Capital Group, and the leadership of Peter Yu, who has a long track record in cross-border private equity. However, the broader SPAC market has become more selective, and there is intense competition for high-quality targets. The mixed outcome of the first Cartesian SPAC, which led to a weakly performing public company, and the ongoing search by the second SPAC, underline that execution risk is real and that sponsor reputation is important but not decisive.

Innovation and R&D

Innovation and R&D CGCT itself does not have products, technology, or research programs. Its “innovation edge,” if any, lies in its stated strategy: to identify a high-growth business with international expansion potential and to help scale it globally. Any real innovation or R&D story will come from the eventual merger partner, not from CGCT as a shell. Until a target is announced, there is no visibility into what technologies, products, or research pipelines might ultimately sit inside the listed entity.

Summary

Cartesian Growth Corporation III is essentially a financial shell waiting to acquire a real operating business. Its current financial statements mostly reflect structure, not performance. The key assets are the sponsor’s experience, cross-border deal network, and stated focus on building long-term global growth companies. The key risks are typical SPAC issues: uncertainty about if and when an attractive deal will be found, how it will be valued and financed, how many shareholders redeem at closing, and how the eventual combined company performs in public markets. Until a specific merger target is identified and disclosed, analysis is less about current numbers and more about trust in the management team and the evolving SPAC environment.